Alvotech (ALVO)
5.54
-0.24
(-4.15%)
USD |
NASDAQ |
Oct 12, 12:06
Alvotech Price : 5.54 for Oct. 12, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 09, 2026 | 5.67 | 5.805 | 5.565 | 5.78 | 707140.0 |
| Oct 08, 2026 | 5.83 | 5.83 | 5.605 | 5.67 | 668880.0 |
| Oct 07, 2026 | 6.10 | 6.14 | 5.845 | 5.85 | 864565.0 |
| Oct 06, 2026 | 6.07 | 6.17 | 6.00 | 6.14 | 1.219M |
| Oct 05, 2026 | 5.99 | 6.53 | 5.90 | 6.11 | 2.899M |
| Oct 02, 2026 | 5.61 | 5.70 | 5.43 | 5.45 | 750933.0 |
| Oct 01, 2026 | 5.81 | 5.82 | 5.46 | 5.62 | 1.202M |
| Sep 30, 2026 | 5.95 | 5.97 | 5.76 | 5.80 | 1.136M |
| Sep 29, 2026 | 6.135 | 6.17 | 5.825 | 5.92 | 1.170M |
| Sep 28, 2026 | 5.73 | 6.17 | 5.675 | 6.15 | 1.436M |
| Sep 25, 2026 | 5.90 | 5.90 | 5.67 | 5.75 | 705190.0 |
| Sep 24, 2026 | 5.75 | 6.06 | 5.75 | 5.88 | 1.199M |
| Sep 23, 2026 | 5.86 | 5.89 | 5.70 | 5.81 | 774268.0 |
| Sep 22, 2026 | 5.90 | 5.97 | 5.715 | 5.84 | 978060.0 |
| Sep 21, 2026 | 5.92 | 5.98 | 5.74 | 5.88 | 1.313M |
| Sep 18, 2026 | 5.40 | 5.985 | 5.395 | 5.87 | 3.536M |
| Sep 17, 2026 | 5.22 | 5.455 | 5.20 | 5.34 | 1.706M |
| Sep 16, 2026 | 5.40 | 5.53 | 5.10 | 5.10 | 3.868M |
| Sep 15, 2026 | 5.05 | 5.07 | 4.90 | 5.02 | 610025.0 |
| Sep 14, 2026 | 5.225 | 5.26 | 5.035 | 5.05 | 674195.0 |
| Sep 11, 2026 | 5.28 | 5.39 | 5.26 | 5.29 | 667872.0 |
| Sep 10, 2026 | 5.21 | 5.34 | 5.14 | 5.24 | 540858.0 |
| Sep 09, 2026 | 5.15 | 5.24 | 5.06 | 5.21 | 572359.0 |
| Sep 08, 2026 | 5.26 | 5.32 | 5.142 | 5.19 | 632635.0 |
| Sep 04, 2026 | 5.31 | 5.40 | 5.205 | 5.32 | 535402.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Agenus, Inc. | 7.52 |
| Amgen, Inc. | 415.21 |
| Regeneron Pharmaceuticals, Inc. | 765.63 |
| Anika Therapeutics, Inc. | 19.78 |
| BioCryst Pharmaceuticals, Inc. | 8.30 |
Price Related Metrics
| PS Ratio | 3.643 |
| Earnings Yield | -10.06% |
| Market Cap | 1.977B |
| Operating PE Ratio | 39.93 |